531040-3 ; 933210
Lehr- und Forschungsgebiet Translationale Hämatologie und Onkologie Also known as:933220ID | I:(DE-82)531040-3_20140620 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article
Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical Routine
European journal of haematology 115(4), 380-390 (2025) [10.1111/ejh.70005]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor–Naive or –Experienced Myelofibrosis Treated With Momelotinib
Clinical lymphoma, myeloma & leukemia 25(3), 199-211 (2025) [10.1016/j.clml.2024.10.001]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing
Pharmacological research 211, 107560 (2025) [10.1016/j.phrs.2024.107560]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Cell Adhesion and Local Cytokine Control on Protein‐Functionalized PNIPAM‐co‐AAc Hydrogel Microcarriers
Small : nano micro 21(2), 2404183 (2024) [10.1002/smll.202404183]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
Ann Hematol 103(7), 2299-2310 (2024) [10.1007/s00277-024-05665-4]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis
Blood : journal of the American Society of Hematology 144(17), 1813-1820 (2024) [10.1182/blood.2024025802]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment
Cancer research 84(18), 2985-3003 (2024) [10.1158/0008-5472.CAN-23-3553]
BibTeX |
EndNote:
XML,
Text |
RIS
Contribution to a book
Ph-negative myeloproliferative Neoplasien
Therapie-Handbuch Onkologie und Hämatologie / Hubert Serve und David Zurmeyer (Hrsg.) ; mit Beiträgen von: Lukas Aguinarte, Frankfurt a.M. [und vielen weiteren]
München : Elsevier, Therapie-Handbuch : 2. Auflage, 219-227 (2024) [10.1016/B978-3-437-21011-2.00031-4]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article/Contribution to a book
Exploiting Synthetic lethality between Germline BRCA1 haploinsufficiency and PARP inhibition in JAK2V617F-positive myeloproliferative neoplasms
International journal of molecular sciences 24(24), 17560 (2023) [10.3390/ijms242417560] special issue: "Novel Therapeutic Targets in Cancers 2.0 / Special Issue Editor: Elena Levantini, Guest Editor"
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Abstract/Journal Article/Contribution to a conference proceedings
The role of SABR in the management of oligometastatic and recurrent head and neck cancers
ESTRO 2023, ESTRO 2023, ViennaVienna, Austria, 13 May 2023 - 16 May 2023
Radiotherapy and oncology 182(Supplement 1), PO-1177 (2023) [10.1016/S0167-8140(23)09174-0] special issue: "ESTRO 2023, 13 - 16 May 2023, Vienna, Austria"
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |